NL-OMON56888Not yet recruitingNot Applicable
Development of Anal Cancer Treatment selection model by Organoids (ACTOR) - ACTOR
niversitair Medisch Centrum Utrecht0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •1. Patients with anal SCC who will start treatment with chemoradiotherapy,
- •Mitomycin C + Capecitabine + radiotherapy; or patients with metastatic anal SCC
- •who will start treatment with either chemotherapy (e.g. carboplatin/paclitaxel)
- •or immunotherapy.
- •2. Patient*s age older than 18 years, willing and able to comply with the
- •protocol as judged by the investigator with a signed informed consent.
Exclusion Criteria
- •1. Safely obtain biopsy: If a biopsy cannot be safely obtained as determined by
- •either the surgeon or the radiologist and/or the treating physician, the
- •patient will be excluded from the study.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-IIRadiotherapy Side EffectAnal CancerNCT05385250Karen-Lise Garm Spindler100
Terminated
Not Applicable
Molecular Genetic and Pathological Studies of Anal TumorsRectal CancerColonic NeoplasmsColon CancerAnal CancerNCT00267787Stanford University7
Recruiting
Unknown
Pilot study of Anal Neoplasia Treatment in people with HIV Evaluation and monitoring (short title: PANTHER)Anal High Grade Squamous Intraepithelial Lesions (HSIL)People living with HIVHuman PapillomavirusSurgery - Surgical techniquesPublic Health - Other public healthInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12624000154505niversity of New South Wales Sydney, NSW, Australia100
Completed
Not Applicable
Shared Decision Making With Anal Cancer Patients on Radiation DoseAnal CancerNCT02785263Vejle Hospital27
Recruiting
Not Applicable
Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).Anal Cancer PatientsNCT06364579Fondazione Policlinico Universitario Agostino Gemelli IRCCS120